Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Long-Term Follow-Up of IV Busulfan (Bu) with Fludarabine (Flu) vs IV Bu with Cyclophosphamide (Cy) as Pre (Allogeneic) Transplant Conditioning Therapy for AML/MDS.

Marcos De Lima, X. Wang, P.F. Thall, D. Couriel, R.B. Jones, E.J. Shpall, U. Popat, S. Giralt, M. Korbling, R. Champlin, B.S. Andersson

Blood (2006) 108 (11): 322.

https://doi.org/10.1182/blood.V108.11.322.322

Published: 2006

Journal Articles

Higher Rate of Thrombotic Thrombocytopenic Pupura (TTP) Associated with Graft Versus Host Disease (GVHD) and Unrelated Donor Bone Marrow Transplantation (BMT).

B. Oran, MD, A. Aleman, MD, E. J. Shpall, MD, C. Hosing, MD, M. Korbling, MD, P. Anderlini, MD, R. Champlin, MD, M. Donato, MD

Blood (2005) 106 (11): 1111.

https://doi.org/10.1182/blood.V106.11.1111.1111

Published: 2005

Journal Articles

Peripheral blood stem cell apheresis in normal donors: the neglected side [letter; comment]

P Anderlini, D Przepiorka, R Champlin, M Korbling

Blood (1996) 88 (9): 3663–3664.

https://doi.org/10.1182/blood.V88.9.3663.bloodjournal8893663

Published: 1996

Journal Articles

Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals

P Anderlini, D Przepiorka, R Champlin, M Korbling

Blood (1996) 88 (8): 2819–2825.

https://doi.org/10.1182/blood.V88.8.2819.bloodjournal8882819

Published: 1996

Journal Articles

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy- 1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease

M Korbling, YO Huh, A Durett, N Mirza, P Miller, H Engel, P Anderlini, K van Besien, M Andreeff, D Przepiorka

Blood (1995) 86 (7): 2842–2848.

https://doi.org/10.1182/blood.V86.7.2842.2842

Published: 1995

Journal Articles

With first successful allogeneic transplantations of apheresis-derived hematopoietic progenitor cells reported, can the recruitment of volunteer matched, unrelated stem cell donors be expanded substantially? [letter]

M Korbling, D Przepiorka, J Gajewski, RE Champlin, KW Chan

Blood (1995) 86 (3): 1235.

https://doi.org/10.1182/blood.V86.3.1235.1235

Published: 1995

Journal Articles

Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts [see comments]

M Korbling, D Przepiorka, YO Huh, H Engel, K van Besien, S Giralt, B Andersson, HD Kleine, D Seong, AB Deisseroth

Blood (1995) 85 (6): 1659–1665.

https://doi.org/10.1182/blood.V85.6.1659.bloodjournal8561659

Published: 1995

Journal Articles

Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging

NC Gorin, P Aegerter, B Auvert, G Meloni, AH Goldstone, A Burnett, A Carella, M Korbling, P Herve, D Maraninchi

Blood (1990) 75 (8): 1606–1614.

https://doi.org/10.1182/blood.V75.8.1606.1606

Published: 1990

Journal Articles

Activation of lymphocytes induced by recombinant human granulocyte- macrophage colony-stimulating factor in patients with malignant lymphoma

AD Ho, R Haas, G Wulf, W Knauf, R Ehrhardt, B Heilig, M Korbling, G Schulz, W Hunstein

Blood (1990) 75 (1): 203–212.

https://doi.org/10.1182/blood.V75.1.203.203

Published: 1990

Journal Articles

T-cell ontogeny after autologous bone marrow transplantation: failure to synthesize interleukin-2 (IL-2) and lack of CD2- and CD3-mediated proliferation by both CD4- and CD8+ cells even in the presence of exogeneous IL-2

S Cayeux, S Meuer, A Pezzutto, M Korbling, R Haas, R Schulz, B Dorken

Blood (1989) 74 (6): 2270–2277.

https://doi.org/10.1182/blood.V74.6.2270.2270

Published: 1989

Journal Articles

Allogeneic mixed lymphocyte reactions during a second round of ontogeny: normal accessory cells did not restore defective interleukin- 2 (IL-2) synthesis in T cells but induced responsiveness to exogeneous IL-2

S Cayeux, S Meuer, A Pezzutto, M Korbling, R Haas, R Schulz, B Dorken

Blood (1989) 74 (6): 2278–2284.

https://doi.org/10.1182/blood.V74.6.2278.2278

Published: 1989

Journal Articles

Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia

M Korbling, W Hunstein, TM Fliedner, S Cayeux, B Dorken, D Fehrentz, R Haas, AD Ho, U Keilholz, W Knauf

Blood (1989) 74 (6): 1898–1904.

https://doi.org/10.1182/blood.V74.6.1898.1898

Published: 1989

Journal Articles

B-cell proliferative and differentiative responses after autologous peripheral blood stem cell or bone marrow transplantation

S Kiesel, A Pezzutto, G Moldenhauer, R Haas, M Korbling, W Hunstein, B Dorken

Blood (1988) 72 (2): 672–678.

https://doi.org/10.1182/blood.V72.2.672.672

Published: 1988

Journal Articles

Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma

M Korbling, B Dorken, AD Ho, A Pezzutto, W Hunstein, TM Fliedner

Blood (1986) 67 (2): 529–532.

https://doi.org/10.1182/blood.V67.2.529.529

Published: 1986

Journal Articles

Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4- hydroperoxycyclophosphamide to purge tumor cells

H Kaizer, RK Stuart, R Brookmeyer, WE Beschorner, HG Braine, WH Burns, DJ Fuller, M Korbling, KF Mangan, R Saral

Blood (1985) 65 (6): 1504–1510.

https://doi.org/10.1182/blood.V65.6.1504.bloodjournal6561504

Published: 1985

Journal Articles

Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement

P De Fabritiis, M Bregni, J Lipton, J Greenberger, L Nadler, L Rothstein, M Korbling, J Ritz, RC Jr Bast

Blood (1985) 65 (5): 1064–1070.

https://doi.org/10.1182/blood.V65.5.1064.1064

Published: 1985

Journal Articles

Procurement of human blood stem cells by continuous-flow centrifugation- -further comment [letter]

M Korbling, W Ross, H Pflieger, R Arnold, TM Fliedner

Blood (1977) 50 (4): 753–754.

https://doi.org/10.1182/blood.V50.4.753.753

Published: 1977

NARROW

Long-Term Follow-Up of IV Busulfan (Bu) with Fludarabine (Flu) vs IV Bu with Cyclophosphamide (Cy) as Pre (Allogeneic) Transplant Conditioning Therapy for AML/MDS.

Higher Rate of Thrombotic Thrombocytopenic Pupura (TTP) Associated with Graft Versus Host Disease (GVHD) and Unrelated Donor Bone Marrow Transplantation (BMT).

Peripheral blood stem cell apheresis in normal donors: the neglected side [letter; comment]

Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy- 1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease

With first successful allogeneic transplantations of apheresis-derived hematopoietic progenitor cells reported, can the recruitment of volunteer matched, unrelated stem cell donors be expanded substantially? [letter]

Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts [see comments]

Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging

Activation of lymphocytes induced by recombinant human granulocyte- macrophage colony-stimulating factor in patients with malignant lymphoma

T-cell ontogeny after autologous bone marrow transplantation: failure to synthesize interleukin-2 (IL-2) and lack of CD2- and CD3-mediated proliferation by both CD4- and CD8+ cells even in the presence of exogeneous IL-2

Allogeneic mixed lymphocyte reactions during a second round of ontogeny: normal accessory cells did not restore defective interleukin- 2 (IL-2) synthesis in T cells but induced responsiveness to exogeneous IL-2

Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia

B-cell proliferative and differentiative responses after autologous peripheral blood stem cell or bone marrow transplantation

Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma

Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4- hydroperoxycyclophosphamide to purge tumor cells

Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement

Procurement of human blood stem cells by continuous-flow centrifugation- -further comment [letter]

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only